Syndax Pharmaceuticals Inc.
SNDX
|
|
| |
|
| Trading Volume | 40,115 |
|
|
24.57 - 11.39 |
| Market Cap Full | $ 1.4B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 8.9% | 10% | -17% | -20.6% |
| Q2 | - | -14.5% | -0.9% | 10.7% |
| Q3 | - | -11.2% | -30.6% | 24.9% |
| Q4 | - | -38.6% | 60.1% | 5.9% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8.9 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -5.2 | 14.4 | 1.5 | -12.5 | -7.5 | 5.6 | 11.9 | -11.2 | - | - | - | -21 |
| 2023 | |||||||||||
| 12.8 | -11.7 | -16.7 | -2.7 | -2.8 | 4.8 | 1.9 | -13.2 | -21.6 | -3 | 18.2 | 29.8 |
| 2022 | |||||||||||
| -25.4 | -3.4 | 10.1 | -1 | -4.1 | 16.6 | 3 | 19.2 | 1.8 | -4.5 | 4.4 | 6.2 |
| 2021 | |||||||||||
| -9.9 | 21.8 | -8.4 | -29.1 | 15.8 | -6.5 | -14.9 | 19.7 | 9.3 | 1.9 | -18 | 37.1 |
| 2020 | |||||||||||
| -2.7 | 8 | 17.2 | 64.1 | -10 | -8.5 | -4.8 | 16.8 | -13.2 | 21.7 | 33.1 | -4 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.6 | -0.6 | -0.5 | -0.6 |
| Q2 | -0.6 | -0.6 | -0.4 | -0.4 |
| Q3 | -0.7 | -0.6 | -0.4 | -0.5 |
| Q4 | 0 | -0.6 | 1.8 | -0.4 |
| A | -1.96 | -2.5 | 0.5 | -1.9 |